Nuclera, the biotechnology company providing rapid access to functional proteins for drug discovery, has completed its first installations in Asia. Systems are now operational at the National ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback